Barrier Insulators in Erythropoiesis
Barrier Insulators in Erythropoiesis
批准号:
8025615
负责人:
PATRICK G GALLAGHER
金额:
$41.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2014-11-30
关键词:
AddressAnimal ModelArchitectureBerylliumBindingBinding ProteinsBiological AssayBiologyCancerousCell Culture TechniquesCellsCellular StructuresCharacteristicsChickensChildChromatinChromosomal translocationComplexCongenital AbnormalityDNA MethylationDataDevelopmentDiseaseElementsEnhancersEnzymesErythroblastsErythrocyte MembraneErythroidErythroid CellsErythropoiesisEuchromatinExhibitsFocus GroupsGene ClusterGene ExpressionGene Expression RegulationGene SilencingGenesGenomicsGoalsGrowth and Development functionHematopoieticHereditary DiseaseHeterochromatinHistocompatibility TestingHistonesHumanIndiumInheritedInsulator ElementsLeadMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMediatingMembrane Protein GeneModelingMolecular ProfilingMultiprotein ComplexesNucleosomesPatternPositioning AttributePrincipal InvestigatorProcessProtein BindingProtein IsoformsProteinsProteomicsRecruitment ActivityRegulationReporter GenesSpecificityStable Isotope LabelingStagingStem cellsStructureTechniquesTechnologyTimeTissue DifferentiationTransgenic MiceWorkbasebeta Globincell growthcell typecellular developmentgenetic elementgenetic regulatory proteingenome-widehistone acetyltransferasehistone methyltransferasehistone modificationhuman datain vivoinsightnovelpreventprogramspromoterstemtranscription factor USFvalidation studies
中文摘要
描述(由申请人提供):屏障绝缘子创建“屏障”以防止异染色质介导的基因沉默,这对于正常发育和分化中细胞类型特异性基因表达的调节至关重要。屏障绝缘子功能的扰动,这经常发生在染色体易位与散发性和遗传性遗传疾病或癌症状态,有助于改变这些条件的基因表达特征。脊椎动物屏障元件的结构和功能知之甚少。本项目的总体目标是定义和表征红细胞生成过程中控制基因表达的屏障绝缘体。目的一的目标是确定一个共同的监管签名与功能性屏障绝缘体在人类红细胞。这些研究解决了这样的假设,即细胞类型特异性屏障绝缘子有一个共同的监管签名,可通过染色质结构识别,蛋白质与组蛋白甲基转移酶和乙酰转移酶活性的结合,ATP依赖性核小体重塑活性和其他监管功能。这一目标将最先进的高通量基因组技术与功能研究相结合。在屏障绝缘体已被确定和功能验证,组蛋白结构,调节蛋白结合,和基因组组织将被整合和分析。目的二的目标是解决USF(上游刺激因子)蛋白募集与激活组蛋白修饰相关的酶和其他蛋白质以阻断导致屏障绝缘体中基因沉默相关的染色质变化扩散的机制的假设。这一假设是基于对来自β珠蛋白基因簇的鸡HS4屏障绝缘子的研究和来自人类红系细胞的初步数据。将评估造血干细胞和祖细胞以及成红细胞中的USF结合,并将其与基因组组织、组蛋白结构和调节蛋白结合整合。第三个目标是表征与红系细胞中屏障绝缘体相关的多蛋白复合物,解决这些复合物包含共同功能的蛋白质的假设,包括组蛋白甲基转移酶和乙酰转移酶,核小体重塑蛋白和其他关键的调节蛋白。多蛋白质复合物的基因表达调控程序的全面分析受到低丰度,动态和上下文依赖的组合物,以及识别复杂成分的技术困难的阻碍。为了克服这些障碍,表征介导屏障绝缘子功能的多蛋白复合物将使用最先进的定量蛋白质组学技术进行。这种方法结合了体内稳定同位素标记蛋白质,集成质谱和计算平台,然后进行验证研究。总之,这些研究将为控制基因表达的关键过程提供新的见解,并最终导致对细胞生长和发育过程中控制特定基因表达程序的调控相互作用的全面理解。
公共卫生相关性:这项提议的目的是了解一个知之甚少,但重要的基因元件是如何在正确的时间在正确的地方打开和关闭基因的。当这种元素不起作用时,细胞可能不起作用,就像出生缺陷的孩子一样,或者可能失去控制,就像癌症一样。了解这个元素可以为我们提供一些疾病如何发生的重要信息,并可以提供如何治疗它们的想法。
英文摘要
DESCRIPTION (provided by applicant): Barrier insulators create a "barrier" to protect against heterochromatin-mediated gene silencing, critical for regulation of cell-type specific gene expression in normal development and differentiation. Perturbation of barrier insulator function, which frequently occurs in chromosomal translocations associated with sporadic and inherited genetic disease or cancerous states, contributes to alterations in gene expression characteristic of these conditions. The structure and function of vertebrate barrier elements are poorly understood. The overall aims of this project are to define and characterize barrier insulators controlling gene expression during erythropoiesis. The goal of aim one is to identify a common regulatory signature associated with functional barrier insulators in human erythroid cells. These studies address the hypothesis that there is a common regulatory signature for cell-type specific barrier insulators recognizable by chromatin architecture, binding of proteins with histone methyltransferase and acetyltransferase activity, ATP-dependent nucleosome remodeling activity, and other regulatory functions. This aim combines state of the art high throughput genomic technologies with functional studies. After barrier insulators have been identified and functionally validated, histone architecture, regulatory protein binding, and genomic organization will be integrated and analyzed. The goal of aim two is to address the hypothesis that USF (upstream stimulatory factor) proteins recruit enzymes and other proteins associated with activating histone modifications to block the mechanism(s) that lead to spreading of gene-silencing associated chromatin changes in barrier insulators. This hypothesis is based on studies of the chicken HS4 barrier insulator from the beta globin gene cluster and preliminary data from human erythroid cells. USF binding in hematopoietic stem and progenitor cells and erythroblasts will be assessed and integrated with genomic organization, histone architecture, and regulatory protein binding. The goal of the third aim is to characterize the multiprotein complexes associated with barrier insulators in erythroid cells, addressing the hypothesis that these complexes contain proteins of common function, including histone methyltransferases and acetyltransferases, nucleosomal remodeling proteins, and other critical regulatory proteins. Comprehensive analyses of multiprotein complexes regulating programs of gene expression have been hampered by low abundance, dynamic and context-dependent composition, and technologic difficulties in identifying complex constituents. To overcome these hurdles, characterization of the multiprotein complexes mediating barrier insulator function will be performed using state-of-the-art, quantitative proteomics techniques. This approach combines protein labeling by stable isotopes in vivo, integrated mass spectrometry and computational platforms, followed by validation studies. Together, these studies will provide novel insight into a critical process controlling gene expression and will ultimately lead to a comprehensive understanding of the regulatory interactions that control specific gene expression programs during cell growth and development.
PUBLIC HEALTH RELEVANCE: The goal of this proposal is to understand how a poorly understood, yet important genetic element that turns genes on and off at the right time in the right place works. When this element doesn't work, cells may not work, as occurs in children born with birth defects, or may grow out of control, as occurs in cancer. Understanding this element may provide us with important information on how some diseases occur and may provide ideas on how to treat them.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Mechanisms of Congenital Dyserythropoietic Anemia
-
批准号:10454333
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2020
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Novel Mechanisms of Congenital Dyserythropoietic Anemia
-
批准号:9887377
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2020
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Novel Mechanisms of Congenital Dyserythropoietic Anemia
-
批准号:10192709
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2020
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis
-
批准号:10305603
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2019
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2
-
批准号:10308706
-
项目类别:
-
资助金额:$54.85万
-
财政年份:2018
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Responsiveness and non-responsiveness to transfused RBCs in mice and humans.
-
批准号:9918440
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2017
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Center of Excellence in Hematology
-
批准号:10454355
-
项目类别:
-
资助金额:$81.39万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9987207
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Center of Excellence in Hematology
-
批准号:10249339
-
项目类别:
-
资助金额:$81.39万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:8972977
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9325318
-
项目类别:
-
资助金额:$80.71万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9763197
-
项目类别:
-
资助金额:$2.36万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9544538
-
项目类别:
-
资助金额:$1.06万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Center of Excellence in Hematology
-
批准号:10060455
-
项目类别:
-
资助金额:$100.19万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9763598
-
项目类别:
-
资助金额:$78.2万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Regulation of Erythrocyte Volume Homeostasis
-
批准号:8927631
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Regulation of Erythrocyte Volume Homeostasis
-
批准号:9921353
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2014
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Regulation of Erythrocyte Volume Homeostasis
-
批准号:9382408
-
项目类别:
-
资助金额:$42.96万
-
财政年份:2014
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Barrier Insulators in Erythropoiesis
-
批准号:8585873
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2011
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Barrier Insulators in Erythropoiesis
-
批准号:8389605
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2011
-
负责人:PATRICK G GALLAGHER
-
依托单位:
海外基金